Reports are emerging from the ASCO GI 2026 event, with various outlets highlighting notable posts and updates in gastrointestinal oncology. The number and focus of these posts vary across outlets, with some specifically mentioning immunotherapy and others referencing practice-changing trials. The event appears to have generated a significant amount of content, with multiple parts and days of coverage being reported.